Feel great knowing that your donation could lead to a breakthrough discovery or help a patient enjoy a better quality of life. Compensation levels are different based on the type of collection performed or special recruitment requests from researchers. When your donation is complete, you’ll be compensated for your time and efforts.
Please call our donor centre for specific details.
It's important for donors to understand the difference between donating blood for transfusion into patients versus use in scientific studies. Blood collections at CTLS support research and are necessary for the advancement of medicine.
Need more reasons to donate blood? Here are five health benefits you may not have known about.
It may not be a familiar term but chances are you've encountered one at a visit to your doctor or an emergency room.
Point-of-care (PoC) testing enables more rapid analysis of patient specimens outside of a lab, near or at the site of patient care. Generally, the "test" is performed by clinical staff without laboratory training and speeds the decision making for diagnosis, treatment choice and monitoring, and prognosis. A PoC test is often a necessary tool for patient self-monitoring, as in the case for insulin dependent diabetics.
Learn how our valued donors contribute to research and development of new PoC testing and the ways donors participate.
All women are at risk for cervical cancer, described as a malignant tumor of the cervix at the lowermost part of the uterus. Historically, treatments have been limited to surgery, radiation and chemotherapy but today, thanks in part to #bloodforresearch, scientist have developed vaccines and immunotherapies that target cervical tumors and improve outcomes.
It's no easy task to bring a vaccine to the public but scientists have been working tirelessly to do just that. Vaccine developers announced positive news regarding COVID-19 vaccine efficacy tests.
A diagnosis of blood cancer, leukemia or lymphoma, was effectively a death sentence 50 years ago. Read about the developments in both diagnosis and treatment options that are changing this.
Want to understand what CAR-T, immuno-oncology and immunotherapy mean to cancer patients? Read this blog by Scientific American for information about the new therapy that has had unprecedented success in blood cancers (leukemia and lymphomas) as well as other tumor types.
This story from Nautilus explores the development of immunotherapy as a powerful cancer treatment.
This article explores how scientists are redirecting the body's immune regulatory system in response to autoimmune disorders such as multiple sclerosis, inflammatory bowel disease, rheumatoid arthritis and more.